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Abstract
Background:  Selective dorsal rhizotomy (SDR) is a well accepted neurosurgical procedure
performed for the relief of spasticity interfering with motor function in children with spastic
cerebral palsy (CP). The goal is to improve function, but long-term outcome studies are rare. The
aims of this study were to evaluate long-term functional outcomes, safety and side effects during
five postoperative years in all children with diplegia undergoing SDR combined with physiotherapy.
Methods: This study group consisted of 35 children, consecutively operated, with spastic diplegia,
of which 26 were Gross Motor Function Classification System (GMFCS) levels III–V. Mean age was
4.5 years (range 2.5–6.6). They were all assessed by the same multidisciplinary team at pre- and at
6, 12, 18 months, 3 and 5 years postoperatively. Clinical and demographic data, complications and
number of rootlets cut were prospectively registered. Deep tendon reflexes and muscle tone were
examined, the latter graded with the modified Ashworth scale. Passive range of motion (PROM)
was measured with a goniometer. Motor function was classified according to the GMFCS and
measured with the Gross Motor Function Measure (GMFM-88) and derived into GMFM-66.
Parent's opinions about the children's performance of skills and activities and the amount of
caregiver assistance were measured with Pediatric Evaluation Disability Inventory (PEDI).
Results: The mean proportion of rootlets cut in S2-L2 was 40%. Muscle tone was immediately
reduced in adductors, hamstrings and dorsiflexors (p < 0.001) with no recurrence of spasticity over
the 5 years. For GMFCS-subgroups I–II, III and IV–V significant improvements during the five years
were seen in PROM for hip abduction, popliteal angle and ankle dorsiflexion (p = 0.001), capacity
of gross motor function (GMFM) (p = 0.001), performance of functional skills and independence in
self-care and mobility (PEDI) (p = 0.001).
Conclusion: SDR is a safe and effective method for reducing spasticity permanently without major
negative side effects. In combination with physiotherapy, in a group of carefully selected and
systematically followed young children with spastic diplegia, it provides lasting functional benefits
over a period of at least five years postoperatively.
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Background
Many children with cerebral palsy (CP) have spasticity
that interferes with motor function and activities in daily
life. A variety of treatment options to reduce spasticity
have been developed [1,2]. As CP is a heterogeneous con-
dition, the treatment should be highly individualized.
Finding the right treatment at the right time for the child
is challenging [3]. The only treatment option to reduce
spasticity permanently is selective dorsal rhizotomy
(SDR). This neurosurgical procedure can be used for the
relief of spasticity interfering with motor function in chil-
dren with CP. As the optimal goal of the operation is to
improve function, it should always be combined with
physiotherapy. SDR was introduced in North America in
the early 1980s and the history of the procedure has been
reviewed elsewhere [4-7]. The operation is usually recom-
mended for young children with CP spastic diplegia, with-
out dyskinesia or ataxia, without significant cognitive
disability and with walking capacity or ambulation within
reach [8-12]. SDR was introduced in Scandinavia in 1993
and is one of several treatment options at Lund University
hospital for young and carefully selected children with
spastic diplegia.
SDR combined with physiotherapy has been proven to be
beneficial in the domains of body function and structure
according to the International Classification of Function-
ing, Disability and Health (ICF) [13]. Lower limb spastic-
ity is consistently relieved and lower limb range of motion
increased [9,10,12,14,15]. Strength and gait speed are
gained [16,17]. Evidence for positive impact in activities
and participation has been reported [15,18-20]. Meta-
analysis data derived from three randomized studies
[9,10,12] concluded that SDR in combination with phys-
iotherapy had a positive effect on gross motor function
one year after the operation. The children who had under-
gone SDR and physiotherapy had a greater functional
improvement than children only receiving physiotherapy.
A direct relationship between percentage of dorsal rootlets
transected and functional improvement was found [21].
Lasting functional improvements in gait have been shown
10 and 20 years after SDR [22,23].
SDR may reduce the need for orthopaedic procedures in
patients with spastic CP if the SDR operation is conducted
before the age of 5 years [24]. SDR has been suggested to
have a positive, rather than negative, effect on the progno-
sis of hip subluxation [25]. With respect to the safety of
SDR, perioperative complications are rare [26]. However,
a high incidence of spinal deformities has been reported
after SDR [27,28]. We are not aware of any previous long-
term follow-up study after SDR with a complete consecu-
tively operated group of children. The aims of this study
were to evaluate long-term functional outcomes, safety
and side effects during five years postoperative follow-up
in a group of children undergoing SDR combined with
physiotherapy who were consecutively operated and sys-
tematically monitored.
Methods
Patients
CP is defined as a motor-impairment syndrome secondary
to early non-progressive lesions or anomalies of the brain
[29]. The CP subtype spastic diplegia has more involve-
ment of the legs than the arms, with or without walking
ability within reach [30]. At the University Hospital of
Lund, SDR is indicated in patients presenting with spastic-
ity as the dominating neurological sign. All children (n =
35) with CP spastic diplegia undergoing SDR in the
period March 1993 to June 1999 were included in the
study. Preoperative gross motor function was classified,
with the Gross Motor Function Classification System
(GMFCS), into a five level ordinal scale where level I rep-
resent the least and level V the greatest functional limita-
tions [31]. The mean age at operation was 4.5 years (range
2.5–6.6 years).
The medical team consisted of neurodevelopmental pae-
diatricians (JL, LW) and physiotherapists (EN, ALJ) and
the selection procedure included thorough and repeated
preoperative clinical evaluations. No neurosurgeon was
involved in the selection procedure. The child's motor
activities and performance were assessed in many situa-
tions including provocation of different neurological
signs at rest and in intensive activities. Selective motor
control, alignment and muscle strength were assessed in
provoked functional activities against gravity e.g. in differ-
ent positions on a Bobath ball, repeated sit-to-stand and
squatting. Neuroimaging was not performed to guide the
selection for SDR during these years.
All children were monitored and examined by the same
team pre- and at 6, 12, 18 months, 3 and 5 years postop-
eratively. The physiotherapist from the local child habili-
tation team and both parents participated in the selection
assessments and discussions pre- and postoperatively.
Preoperative characteristics of the children are presented
in Table 1. Perinatal asphyxia was defined as Apgar score
≤ 3 at 5 minutes and/or hypoxic ischemic encephalopathy
with convulsions during the first 72 hours. Epilepsy was
defined as active epilepsy requiring medical treatment.
Information about the cognitive function was updated at
the five year postoperative follow-up. Severe cognitive dis-
ability was defined as learning disability (mental retarda-
tion) corresponding to Intelligence Quotient (IQ) below
50, moderate cognitive disability to IQ between 50 and
70.BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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Severe visual disability was defined as functional blind-
ness or binocular acuity of < 0.3 after correction of refrac-
tion errors.
The Swedish reference population growth curves were
used [32]. Overweight was arbitrarily defined, in this
study, as Body Mass Index (BMI) > + 2 SD for age and gen-
der, underweight as BMI < -2 SD and/or weight for age
and gender < – 2.5 SD.
Selection criteria for SDR
Children below seven years of age with CP subtype spastic
diplegia were selected for the operation. Spasticity inter-
fering with present and future motor function and activi-
ties in daily life was considered an indication in all
GMFCS levels, also when walking ability was out of reach.
It was important that the child received and was willing to
receive physiotherapy pre- and postoperatively. Cognitive
disability was not considered a contraindication as long as
the child had a drive to move and play. Contraindications
were the presence of dystonia, ataxia, fixed contractures or
earlier orthopaedic operations other than adductor tenot-
omy.
Treatment goals
The family and the child's local therapist actively partici-
pated in the pre- and postoperative discussions and deci-
sions regarding realistic expectations, goal setting and
interventions. Individual functional goals for the inter-
vention were set. The overall goals were to improve motor
and functional skills e.g. improvement of alignment, bal-
ance in sitting and standing, transfers, walking and/or
wheeled mobility. Additional desirable effects from the
spasticity reduction were prevention of severe contrac-
tures, hip dislocation and pain.
For the children with independent walking ability GMFCS
levels I–II the functional goals were to improve balance,
endurance, flexibility in standing, walking, running jump-
ing. For children in GMFCS level III goals were directed
towards stability and variability in sitting, attain and
maintain standing, walking and enabling self-propelled
wheeled transfers. For the children in GMFCS levels IV–V
the functional goals were independent sitting, supported
standing and enabling of wheelchair transfers. Other
goals, although not scientifically evaluated, were to reduce
pain emerging from spasticity and inactivity as well as the
daily care burden for the caregivers.
Table 1: Patients.
Child characteristics n = 35
Boys/girls 24:11
Age at operation: mean, SD, range (years) 4.5, 1.1, (2.5–6.6)
Preoperative GMFCS levels:
I 1
II 8
III 10
IV 15
V 1
Gestational age (completed weeks):
< 26 3
26–27 2
28–31 19
32–36 4
37–42 5
> 42 0
Premature, gestational age not specified 2
Birth weight (g): mean, range 1689 (710–3370)
Twin/triplet 7/1
Perinatal asphyxia: yes/no/unknown 3/28/4
a Shunted hydrocephalus: yes/no 8/27
b Intraventricular haemorrhage: yes/no/not studied 10/8/17
c Periventricular atrophy: yes/no/not studied 13/6/16
Any of a, b, c above: yes/no/not studied 21/6/8
Epilepsy pre-op: yes/no 5/30
Cognitive disability: severe/moderate/no or minor 3/7/25
Severe visual impairment 3
Overweight/underweight preoperatively 2/11
Overweight/underweight 5 years postoperatively 4/4BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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Postoperative physiotherapy
After the operation, the child stayed in the intensive care
unit for 3–5 days. Following transferal to the children's
hospital, daily physiotherapy was started on the 5th post-
operative day and continued for a total of three weeks:
one week at the Children's hospital and the two following
weeks at the regional habilitation centre.
The first week of physiotherapy treatment focused on
mobilization: rolling, sitting, functional activities and
standing for periods of 45 minutes twice a day. During the
second and third week of physiotherapy, a further session
of 45 minutes was added daily. The physiotherapy was
incorporated into the child's daily activities, promoting
functional skills in playing, dressing, grooming, transfers
and mobility. Hydrotherapy was introduced as soon as
the scar had healed.
After discharge from the habilitation centre, the local ther-
apist continued to implement functional activities and
participation in daily activities. The recommended fre-
quency of individualized treatment sessions for the first
six months was one hour twice a week and thereafter once
a week. In addition, physical leisure activities were
encouraged. However, hippotherapy was not recom-
mended until six months postoperatively.
Two months after discharge, the patient was seen by the
neuropaediatrician and physiotherapist to support the
rehabilitation process. All information collected during
the pre-, peri- and postoperative assessments was docu-
mented in the medical records and study protocols.
Neurosurgery and anesthesia
The children were premedicated with midazolam. Gen-
eral anaesthesia was induced with intravenous fentanyl
and thiopental. Succinylcholine was given to facilitate tra-
cheal intubation, followed by one dose of muscle relax-
ant. Anaesthesia was maintained with isoflurane/N2O/
O2 and fentanyl. All children had a urinary bladder cath-
eter. The operation technique described by Peacock was
used [7,33,34]. A block laminoplasty was performed from
L1 to L5. The dura was opened and the cauda equina
exposed. The posterior roots were identified and the level
was confirmed by visible anatomical features and by using
electrical stimulation. Each root was divided into rootlets
and stimulated. This process was facilitated by the inven-
tion of a new instrument, in the shape of a comb, where
the rootlets could be placed and kept separated.
Postoperatively, the children were either treated with
intrathecal (IT) morphine and rectal paracetamol every 6
hours or continuous infusion of IT bupivacain and mor-
phine by a pump. All children received supplementary
intravenous cetobemidon if necessary. Dose reduction
was initiated 64 h after the operation and the IT treatment
was terminated 48 h later as previously described [35]. All
children received prophylactic intravenous antibiotics
postoperatively.
Neurophysiology
EMG recordings were obtained from the adductor, vastus
lateralis, tibialis anterior, hamstrings and gastrocnemius
muscles bilaterally, as well as from the external anal
sphincter. Two silver wires, insulated except for the tip,
were inserted into each muscle belly. In the external anal
sphincter (EAS), they were inserted at 3 and 9 o'clock, and
in the hamstrings, one wire was inserted into the medial
and one into the lateral hamstrings. Stimulation of the
roots was done through handheld cauterizing forceps
connected to a constant current stimulator, pulse width
0.1 ms. The electromyography (EMG) responses were
recorded with a Nihon-Kohden electroencephalogram
recorder, paper speed of 20 mm/s. The amplifier had a
low pass filter at 120 Hz and a time constant at 0.003s.
Initially, ventral roots were stimulated with single pulses
(usually 0.1–0.3 mA) to identify the S1 and S2 roots. In
addition to EMG responses, the legs were inspected visu-
ally to detect toe flexion. Stimulation of the S2 root
evoked responses in the external anal sphincter and toe
flexors. Stimulation of the S1 root activated the ham-
strings and gastrocnemius muscles and, to a lesser extent,
the EAS. Once the root levels had been identified, the dor-
sal roots were stimulated with a pulse train (1 s, 50 Hz).
Stimulus strength was, in most cases, below 2 mA. The S2
to the L2 roots were stimulated first. This was done in
order to identify from which segments the most patholog-
ical reflex responses would be expected. Also, if stimula-
tion of a root did not evoke any reflex response, this root
was not divided into rootlets and considered for rhizot-
omy. Likewise, if the S2 root gave rise to EAS responses
only and no toe flexion, the root was left intact. When a
root had been divided into rootlets, all of these were stim-
ulated before deciding which ones to cut or to spare. This
was done to ensure that the rootlets with the most patho-
logical reflex responses were cut. The number of rootlets
cut was determined from the occurrence of pathological
reflex responses in combination with preoperative assess-
ments of spasticity interfering with motor function.
The number of sectioned rootlets was presented as the
percentage of the total number of rootlets. However,
since, in some cases, the S2 and/or L4 roots were left intact
without being divided into rootlets, the median number
of rootlets obtained from the other children was used for
the calculation. For S2, this was six rootlets and, for L4,
nine.BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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Pre- and postoperative clinical examination and 
assessments
The families were questioned about the child's appetite
and sleep, micturition and bowel habits, epilepsy, infec-
tions including urinary tract infections and other health
problems preoperatively, at discharge from the habilita-
tion centre, and at all postoperative controls. In addition,
pain and sensory disturbances such as hypo- and hyperes-
tesia were investigated. The scar after the SDR operation
was inspected. The spine was clinically screened for scol-
iosis, hyperlordosis, kyphosis and pain/discomfort. Blad-
der scan or full urinary tract ultrasound examinations
were performed to measure bladder emptying before and
six months after SDR for all children operated 1997 and
later. Weight and height were measured in a standardized
manner preoperatively and at all follow-ups and plotted
into Swedish growth charts [32,36].
At the pre- and postoperative follow-ups, deep tendon
reflexes and clonus in the extremities were examined for
each child by the same neuropaediatrician (JL or LW). The
degree of deep tendon reflex response was rated in a 5-
point scale, the National Institute of Neurological Disor-
ders and Stroke (NINDS) scale [37]. Clonus was graded in
a three point scale: no clonus, 1–6 beats, and ≥ 7 beats, i.e.
inextinguishable clonus.
The muscle tone of the hip adductors, hamstrings and
ankle plantar flexors was rated with the Ashworth scale,
modified by Peacock, ranging from hypotonic (0) to parts
rigid in flexion and extension (5) [7]. Passive range of
motion (PROM) was measured for hip abduction with the
knees extended, for popliteal angle and for ankle dorsi-
flexion with the knee extended and the foot inverted. The
joint angles were measured at maximal range of move-
ment with the use of a goniometer and standardised ana-
tomical landmarks and methods as per the American
Academy of Orthopedic Surgeons [38].
Spinal radiographs were performed preoperatively prima-
rily to discover spinal anomalies that could interfere with
the operation technique surgical procedure. Hip radio-
graphs were taken in anterioposterior position preopera-
tively and were also performed at least at 5 years post SDR,
migration percentage (MP) was calculated to identify hip
subluxation.
Outcome measures
The Gross Motor Function Measure (GMFM) is a measure
of a child's gross motor function in a standardised obser-
vational way. It was designed to yield an index of gross
motor function enabling changes in function to be evalu-
ated after interventions or monitored over time for chil-
dren with CP. The GMFM is a criterion-referenced
measure based on normal gross motor developmental
mile stones; all items are achievable by a five-year old
child without any motor disability. GMFM has three scor-
ing alternatives for total scores; GMFM-88 total, goal total
score and GMFM-66. Also in GMFM-88 it is possible to
obtain scores for five separate dimensions A. Lying and
rolling; B. Sitting; C. Crawling and kneeling; D. Standing
and E. Walking, running and jumping [39]. A goal total
score was calculated for each child as the mean of the indi-
vidually selected GMFM dimension scores. The dimen-
sions were selected based on the child's functional status,
age and areas of interests. The children were tested and
videotaped by the same PTs (EN and ALJ) at all follow-
ups. GMFM-88 total, goal total scores and dimension
scores were calculated. However, one child was not tested
in GMFM dimension A at the assessment preoperatively.
Therefore, GMFM-88 total score was not calculated for
this child. By using the Gross Motor Ability Estimator
(GMAE), a GMFM-66 score was obtained for all children
[39].
The Pediatric Evaluation of Disability Inventory (PEDI) is
a generic standardised instrument used by the multidisci-
plinary team for evaluating functional performance, pro-
gramme monitoring, documentation of functional
development and clinical decision-making [40]. The tar-
get group is children aged 0.5–7.5 years. However it is also
suitable for children older than 7.5 years if their func-
tional ability is below that of non-disabled 7.5 year-olds.
The PEDI contains 197 items in three dimensions; func-
tional skills, caregiver's assistance and modifications/
adaptive equipment used. Each dimension has three
domains: self-care, mobility and social function. Norma-
tive scores are available to the age of 7.5 years; scaled
scores can be used for all ages [40]. In this study, the PEDI
was completed preoperatively and at follow-ups as a struc-
tured interview of parents by the same PT (EN) using the
Swedish translation of PEDI [41]. We have chosen to
present the results of scaled scores from the two dimen-
sions Functional Skills and Caregiver's Assistance in the
two domains Self-care and Mobility. PEDI was introduced
in 1994, thus five of the children operated before 1994
have no PEDI data.
Ethics
According to Swedish National Board of Health and Wel-
fare, clinicians are obliged to secure the quality of care by
performing and reporting results of clinical studies in eve-
ryday practise. Approval from an internal review board is
not required for this type of research. All participants or
caregivers gave their informed consent to participate in
this follow-up. Participants and all data have been han-
dled according to the Helsinki convention.BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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Data analysis – statistics
Nonparametric statistics were used. Friedman's test was
performed to explore change over time (preoperatively, 6,
12, 18 months, 3 and 5 years) for GMFM-88 total and goal
score, GMFM-66 scores and PEDI Scaled scores for Func-
tional skills and Caregiver Assistance in Self-care and
Mobility. Wilcoxon's signed rank's test was used to deter-
mine more specifically at what time during follow-up sta-
tistically significant changes in function appeared (in the
intervals pre- 6 months, pre- 12 months, pre-18 months,
pre- 3 years and pre- 5 years postoperatively). To examine
the relationship between the percentage of cut rootlets
and GMFCS levels, Spearman correlation was performed.
Significance levels were set to p ≤ 0.01 to correct for mul-
tiple comparisons. The Statistical Package of Social Sci-
ences (SPSS 15.0) was used for calculations.
Results
All 35 children attended all five follow-up appointments
during the five years, but did not complete all items.
Outcomes on body function and body structure
The mean proportion of transected rootlets was 40% (SD
± 5, range 25–53) (Table 2).
After SDR, the deep tendon reflexes decreased (p < 0.001)
in the lower extremities. In most cases, they were com-
pletely extinguished. No further change occurred during
the five years follow-up. The biceps reflexes in the upper
extremities also decreased after the SDR (p < 0.01).
Preoperatively, 32 of the 35 children had ankle clonus. In
23, it was inextinguishable. Postoperatively, ankle clonus
was present in only three children, who were among the
four first operated. At that time, transection of rootlets in
S2 was restricted because of fear of bladder dysfunction.
When clonus was gone postoperatively, it did not reap-
pear.
Muscle tone in hip adductors, hamstrings and ankle
plantar flexors decreased (p < 0.001) between preopera-
tive and six months postoperative follow-ups and
remained reduced over the five years.
PROM increased during the whole 5 years period for hip
abduction, popliteal angle and ankle dorsiflexion for the
group as a whole (p > 0.001). The largest changes were
detected at six months after SDR. Children in the GMFCS
I–II sub-group showed statistically significant improve-
ments for ankle dorsiflexors (p = 0.008) and children in
GMFCS III increased hip abduction (p = 0.009). For chil-
dren in GMFCS IV–V, statistically significant improve-
ments were seen in hip abduction (p = 0.001) and
popliteal angle (p = 0.004). Between 3 and 5 years post-
operatively, there was a tendency for decreased popliteal
angle for all children, especially for those in GMFCS III.
One child (GMFCS IV) had undergone orthopaedic sur-
gery before SDR; a bilateral adductor tenotomy. During
the first five postoperative years, 15 children (42%) had
orthopaedic surgery in the lower extremities, as previously
reported for the same cohort [42]. The surgical interven-
tions addressed distal structures in 10 children, mainly
subtalar arthrodesis and achilles tenotomy. Preoperatively
10 hips in seven children had MP > 33%. At five year fol-
low-up, eight of the preoperatively ten hips with MP >
33% had improved, two had deteriorated of which one
had been referred to hip surgery (rotational osteotomy) to
prevent hip dislocation.
Increased lumbar lordosis was observed in four patients at
the five years follow-up. Three patients (GMFCS II, III and
IV) had spondylolisthesis according to the radiographs.
One of these children had occasionally back pain while
the other two had no back symptoms. Five children had
developed scoliosis (Cobb angles 11–23°). None of the
children had a brace or had undergone spinal surgery at
the five-year follow-up.
Functional outcomes
The largest changes in scores between preoperative and 5
years were seen in the GMFCS levels I–II subgroup and the
least changes in the GMFCS levels IV–V subgroup. For
GMFM-66 for the separate GMFCS subgroups, significant
changes were seen over the five years with Friedman's test
(Table 3). Individual GMFM-66 development during the
5 years in the different GMFCS subgroups is illustrated in
Table 2: The amount of transected lumbal (L) and sacral (S) rootlets (%).
Root levels GMFCS levels I–V (n = 35) GMFCS levels I–II (n = 9) GMFCS level III (n = 10) GMFCS levels IV–V (n = 16)
Mean SD Range Mean SD Range Mean SD Range Mean SD Range
L2 49 13.0 (20-75) 40 11.3 (20-62.5) 51 14.6 (25-75) 52 10.9 (20-70)
L3 42 16.1 (0-75) 32 11.4 (14-50) 50 15.5 (22-75) 42 16.0 (0-66)
L4 26 15.7 (0-71) 20 15.7 (0-50) 28 20.5 (0-57) 28 11.4 (0-57)
L5 44 15.9 (0-63) 43 16.0 (0-56) 34 18.6 (0-61) 51 9.6 (23-62.5)
S1 57 12.6 (17-83) 59 10.8 (40-83) 54 14.7 (17-71) 58 12.3 (25-75)
S2 10 12.7 (0-60) 12 12.2 (0-33) 9 10.6 (0-33) 10 14.3 (0-60)
L2-S2 40 4.8 (26-53) 37 3.2 (30-43) 39 5.2 (26-46) 42 4.4 (33-53)BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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Figures 1, 2, 3, and individual GMFM-88 goal total scores
in Figures 4, 5, 6. GMFM-66, GMFM-88 total and goal
total scores showed statistically significant changes using
the Wilcoxon's signed rank's test for the group as a whole
at 1, 3 and 5 years postoperatively (Table 4).
There were no statistically significant differences (Wil-
coxon's signed rank's test) in GMFM-66 during the first 6
months, either for the whole group or for the GMFCS sub-
groups. For the whole group, statistically significant
changes in GMFM-66 score were seen from 12 months
postoperatively (pre- to 12 months postoperatively) and
at all later follow-ups during the five years (pre- to 18
months, pre- to 3 years and pre- to 5 years postopera-
tively). For GMFCS levels I–II, changes were not statisti-
cally significant during follow-ups. Children in GMFCS III
showed statistically significant changes after 3 and 5 years
postoperatively and the children in GMFCS IV–V at 18
months, 3 and 5 years postoperatively.
The PEDI results for the whole group (n = 30) showed sta-
tistically significant changes (p < 0.001) with Friedman's
test in the dimensions Functional Skills (Table 5) and Car-
egiver Assistance (Table 6) for the domains Self-care and
Mobility. Statistically significant changes for scaled scores
in both dimensions and domains were detected by the
Wilcoxon's signed ranks test preoperatively to all postop-
erative follow-ups (pre- to 6 months, pre- to 12 months,
pre- to 18 months, pre- to 3 years and pre- to 5 years post-
GMFM-66 development during five years postoperatively for  individuals in the GMFCS levels I–II (n = 9) Figure 1
GMFM-66 development during five years postopera-
tively for individuals in the GMFCS levels I–II (n = 9).
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GMFM-66 development during five years postoperatively for  individuals in the GMFCS level III (n = 10) Figure 2
GMFM-66 development during five years postopera-
tively for individuals in the GMFCS level III (n = 10).
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GMFM-66 development during five years postoperatively for  individuals in the GMFCS levels IV–V (n = 16) Figure 3
GMFM-66 development during five years postopera-
tively for individuals in the GMFCS levels IV–V (n = 
16).
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operatively) for the whole group and for GMFCS IV–V.
For children in GMFCS subgroups I–II (n = 8) and III (n =
7), there were no statistically significant improvements.
Postoperative medical observations
No major complications occurred peri- or postopera-
tively. In one child, laryngospasm occurred during the
anaesthesia. One child had pneumonia, two obstructive
bronchitis and three urinary tract infection during the first
postoperative week. Four children had cerebral spinal
fluid leakage for a few days. Four children had insufficient
postoperative pain control, while five had pain break-
through which was easily treated. Four children had tran-
sient problems with micturition after removal of the
indwelling catheter. Dysesthesia was common, mostly of
2–3 weeks duration. Muscle spasms in thighs and back
occurred in five children and were treated with diazepam
with good effect. Twelve children had constipation prob-
lems the first weeks. All children could be discharged from
the hospital after 3 1/2 weeks according to the preopera-
tive plan.
Twenty-seven of the 35 children had no problems at all
with micturition, bowel habits, sleep or pain during the
period three months to five years postoperatively. Occa-
sional urinary infection or incontinence, constipation or
sleep problems were present in seven children during the
follow-up period; while one had intermittent back pain
five years post SDR. No new urinary tract problems,
including incontinence, were present after the SDR-oper-
ation. Many children had problems with constipation pre-
operatively, in five the problems disappeared
postoperatively. Nine still needed medication for consti-
pation five years postoperatively.
Five years postoperatively, the two children with preoper-
ative overweight were still obese and two others had
become overweight. One child had acquired underweight.
Three of the 11, children who were underweight before
the operation, were still underweight.
Sensory problems ascribed to the surgical procedure were
dys- or hyperaesthesia, which had disappeared, in all but
Individual GMFM goal total scores (%) for children in GMFCS-level I (n = 1*) and level II (n = 8), preoperatively, 6, 12, 18  months, 3 and 5 years postoperatively Figure 4
Individual GMFM goal total scores (%) for children in GMFCS-level I (n = 1*) and level II (n = 8), preoperatively, 
6, 12, 18 months, 3 and 5 years postoperatively. The children are presented according to age at operation (beginning 
with the youngest child in the respective subgroup).
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three children, six months postoperatively. One child had
recurrent hyperaesthesia and flexor spasms during febrile
infections, the sensory problems were successfully treated
with anti-epileptic medication. One child had recurrent
wounds on the lateral aspect of the left fifth toe with clin-
ical signs of hyposensitivity. One child had persistent
problems with keloid formation in the scar and itching
five years postoperatively.
Discussion
Our results support that SDR is a safe, effective, durable
spasticity-reducing treatment for children with spastic
diplegia in all GMFCS levels. SDR reduces spasticity
immediately and permanently. The mean proportion of
transected rootlets in our study was in accordance with the
meta-analysis study made by McLaughlin et al. [21]. In
combination with physiotherapy, it leads to a beneficial
outcome of quantitative gross motor function, perform-
ance of functional skills and activities, as well as increased
independence in self-care and mobility at least up to 5
years postoperatively. These results are in accordance with
recent studies [18,19,26,43]. No serious complications
due to the surgical intervention occurred. The instrument
constructed to separate the rootlets from each other made
the procedure of stimulation, selection and transection of
the rootlets safe.
This is a prospective long-term follow-up study of a con-
secutive, complete series of SDR-operated children. When
introducing SDR in 1993 we did not have the possibility
to create a comparison group. Instead we chose regular
and thorough follow-ups and a long-term perspective on
development of different aspects of function, a practice-
based evidence approach to evaluate the outcome [44,45].
The appropriate selection criteria are crucial and it is sug-
gested that preoperative diagnosis is the strongest predic-
tor of outcome after SDR [8]. The selection criteria
formulated by Peacock have not been changed during the
study period [7]. However we did not exclude children
with cognitive disabilities if they had a drive to move and
interact in playful treatment situations. Children had to
have spasticity which seriously interfered with and inhib-
ited their further motor function development and daily
care. As described by Steinbok [43]; it is critical to ascer-
tain what the expectations and hopes of the parents or car-
Individual GMFM goal total scores (%) for children in GMFCS-level III (n = 10), preoperatively, 6, 12, 18 months, 3 and 5 years  postoperatively Figure 5
Individual GMFM goal total scores (%) for children in GMFCS-level III (n = 10), preoperatively, 6, 12, 18 
months, 3 and 5 years postoperatively. The children are presented according to age at operation (beginning with the 
youngest child in the respective subgroup).

0
10
20
30
40
50
60
70
80
90
100
3.3 3.6 3.9 4.2 5.1 5.3 5.7 5.8 6.0 6.6
Age at SDR (years)
G
o
a
l
 
t
o
t
a
l
 
s
c
o
r
e
 
(
%
)
  pre
6m
12m
18m
3yrs
5yrsBMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
Page 10 of 15
(page number not for citation purposes)
egivers are and to ensure that they are realistic. One must
discuss what happens when part of the spasticity is
relieved and in what situations the child might have had
use of preserved spasticity i.e. weight-bearing, standing,
mobility, transfers and self-care. This is important to con-
sider for both the children with and without ability or
potential to walk.
The selected children were young and had not yet devel-
oped manifest contractures. The importance of an early
SDR operation has been stressed by orthopaedic surgeons
[24]. Our experience is that children at an age of 2–5 years
are easy to motivate and engage in playful physiotherapy
sessions. This is a time, before school starts, when it is nat-
ural and easy to focus on activities in locomotion and
mobility. Fifteen (42%) of the children in this cohort had
undergone minor orthopaedic surgery (mainly to address
planovalgus) at 5 year follow-up [42]. There are variability
of rates of orthopaedic surgery depending on age, severity
and different indications for ortopaedic surgery between
centers. Subramanian et al. reported the need for addi-
tional orthopaedic surgery after SDR in 65% [23] and Car-
oll et al. in 45% [46]. O'Brien et al. found lower rates of
orthopaedic surgery for children undergoing SDR in the
ages 2–5 years (34%) than for children undergoing SDR
in the ages 6–14 years (70%) [24].
Individual GMFM goal total scores (%) for children in GMFCS-levels IV (n = 15) and V (n = 1*), preoperatively, 6, 12, 18  months, 3 and 5 years postoperatively Figure 6
Individual GMFM goal total scores (%) for children in GMFCS-levels IV (n = 15) and V (n = 1*), preoperatively, 
6, 12, 18 months, 3 and 5 years postoperatively. The children are presented according to age at operation (beginning 
with the youngest child).
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Table 3: GMFM-66 baseline and mean change scores during 5 years.
GMFCS level Baseline Preop-6 m 6–12 m 12–18 m 18 m-3 yrs 3–5 yrs
Mean(SD) Range Mean(SD) Range Mean(SD) Range Mean(SD) Range Mean(SD) Range Mean(SD) Range
I–II 58.6 (8.9) 2.8 (4.9) 5.5 (4.4) -1.2 (5.1) 7.5 (4.7) 2.1 (4.4)
47.3–71.2 -5.5–10 0–13.7 -13.0–3.2 1.0–17.7 -4.1–9.1
III 49.9 (3.0) 1.0 (4.9) 1.8 (3.1) 1.3 (4.1) 2.2 (4.1) 3.7 (3.5)
43.3–53.1 -6.5–9.8 -5.0–6.6 -3.0–8.5 -2.2–8.7 -2.5–7.4
IV–V 40.1 (5.8) 1.4 (3.1) 1.0 (2.0) 1.2 (2.0) 1.2 (3.7) 0.3 (2.5)
31.2–51.1 -4.5–6.3 -2.8–4.8 -3.4–4.0 -2.6–11.9 -3.0–6.5
I–V 47.6 (9.8) 1.6 (4.0) 2.4 (3.5) 0.6 (3.5) 3.1 (4.8) 1.8 (3.6)
31.2–71.2 -6.5–10.9 -5.0–13.7 -13.0–8.5 -2.6–17.7 -4.1–9.1
Mean baseline and change scores, standard deviation (SD) and range for GMFCS levels I–II (n = 9), III (n = 10), IV–V (n = 16) and GMFCS I–V (n = 
35). P-values are obtained from Friedman's test for the GMFM-66 scores: pre-, 6, 12, 18 months, 3 and 5 years postoperatively.BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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It has also been discussed if SDR has a positive or a nega-
tive influence on the development of spinal deformities.
Golan et al. [47] found that younger age at surgery was
associated with a lower rate of hyperlordosis/spinal
deformities. They also reported mild scoliosis in 45% and
19% spondylolisthesis in a sample of 98 children under-
going SDR with follow-up radiographs at a mean of 5.8
years after SDR. Farmer et al. [26] also showed that chil-
dren who had undergone SDR before five years of age had
less lumbar lordosis than the children operated at an
older age. In our study, two of the four children with
increased lumbar lordosis at follow-up were below the age
of 5 years (4.0 and 4.1) when undergoing SDR. Five years
postoperatively, none of the children in our series had
needed any treatment for spinal deformity. These results
are in accordance with the study by Golan et al. in which
no child experienced clinically significant deficits [47].
Long lasting benefits in PROM were seen for the group as
a whole in hip abduction and ankle dorsiflexors. How-
ever, between three and five years postoperatively, there
was a tendency for a decreased range of motion in the
popliteal angle especially for GMFCS III. This is an impor-
tant observation for postoperative treatment planning.
The overall positive results of PROM in this group of chil-
dren might be due to multiple factors including low age at
SDR, recommendations to children in all GMFCS levels to
use a standing shell for at least 1–2 hours per day, regular
follow-ups with goal directed physiotherapy interventions
and use of orthoses. Probably all additional treatments
above have gained PROM development and hip status.
The isolated role of SDR is not examined by this study
design. Severe contractures and hip subluxation are rare in
our sample, but we cannot state a lower frequency of con-
tractures than without SDR, due to lack of information
about contracture development in other children with
spastic diplegia.
Children with cerebral palsy (CP) are generally short and
many, especially non-ambulating children are severely
underweight and stunted [48]. There are no longitudinal
growth data on optimally fed children with CP and there-
fore, we chose to use the reference population growth
curves. The arbitrarily chosen BMI and weight cut-off for
over- and under-weight in this study were wider than the
WHO definitions for typically developing children. In the
present study, many of the children who were preopera-
tively underweight normalized their weight, probably as a
consequence of the loss of the preoperative spasticity
Table 4: GMFM results.
GMFM score Preop-12 m Preop-3 yrs Preop-5 yrs
Mean SD range p-value Mean SD range p-value Mean SD range p-value
GMFM-66
(n = 35) 3.5 4.8 -3.8-19.5 < 0.001 8.0 8.1 -9.9-29.4 < 0.001 9.5 9.7 -7.4-38.4 < 0.001
GMFM-88
total (n = 34)* 10.9 10.3 -9.0-31.0 < 0.001 16.1 12.9 -4.0-52.0 < 0.001 21.2 17.9 -6.9-17.9 < 0.001
GMFM-88
goal total (n = 35) 13.6 13.1 -10.0-42.2 < 0.001 23.6 17.4 -17.0-59.0 < 0.001 25.2 18.7 -21.3-59.0 < 0.001
Mean difference, standard deviation (SD) and range in GMFM-66, GMFM-88 total and goal total scores in children with spastic diplegia. P-values 
obtained with Wilcoxon's signed rank's test: pre- to12 months postoperatively, pre- to 3 years postoperatively, pre- to 5 years postoperatively. 
*One child was not tested in dimension A.
Table 5: PEDI scaled scores functional skills; self care and mobility.
Preop
Mean (SD)
6 m
Mean (SD)
12 m
Mean (SD)
18 m
Mean (SD)
3 yrs
Mean (SD)
5 yrs
Mean (SD)
p-value
Functional Skills, Self-care
GMFCS I–II 63.3 (9.1) 69.1 (10.4) 72.3 (10.4) 72.1 (7.0) 77.4 (7.3) 91.8 (10.1) < 0.001
GMFCS III 59.6 (9.1) 64.0 (9.0) 65.2 (9.7) 67.2 (9.8) 70.7 (13.9) 75.9 (14.8) NS
GMFCS IV–V 46.7 (6.2) 51.5 (6.6) 66.6 (6.8) 55.6 (6.8) 59.5 (8.1) 59.6 (8.3) < 0.001
GMFCS I–V 54.2 (10.7) 59.1 (11.3) 61.4 (11.6) 62.7 (10.5) 66.9 (12.1) 72.0 (17.2) < 0.001
Functional Skills, Mobility
GMFCS I–II 63.9 (8.8) 71.8 (11.6) 75.1 (10.7) 79.7 (12.7) 82.8 (13.5) 86.0 (13.5) < 0.001
GMFCS III 51.1 (9.1) 60.3 (9.0) 62.7 (5.8) 64.2 (9.8) 67.7 (6.2) 73.4 (11.8) < 0.001
GMFCS IV–V 35.4 (7.6) 42.6 (8.3) 46.9 (8.1) 48.4 (8.1) 52.8 (8.5) 52.3 (14.3) < 0.001
GMFCS I–V 46.7 (14.7) 54.6 (15.7) 58.1 (14.7) 60.5 (16.5) 64.2 (15.9) 66.2 (19.8) < 0.001
Mean value, Standard deviation (SD) for all assessments in GMFCS I–II (n = 8), GMFCS III (n = 7), GMFCS IV–V (n = 15) and the group as a whole 
GMFCS I–V (n = 30). P-values obtained with Friedman's test: pre- 6, 12, 18 months, 3 and 5 years postoperatively.BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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induced energy consumption. The rate of weight gain
needs to be brought to attention and dealt with as the chil-
dren are getting older, taller and heavier. It is of great
importance to avoid contractures and weakness at the
knees to prevent crouch position due to lever-arm dys-
function, too much sitting and lack of activity.
The impact of growth, additional treatment, such as
amount of physiotherapy, and orthopaedic surgery are
confounding factors in the long-term follow-up after SDR.
We regard the different intervention options as comple-
mentary rather than exclusive and inform our patients
and families accordingly. Thus a continued multidiscipli-
nary interaction and follow-up is necessary. Regular and
systematic follow-up is of great importance especially dur-
ing growth spurts.
We have chosen to use multiple evaluative and standard-
ized classifications and measures on body function and
structure, and on activities and participation as an integral
part of our clinical routines. The GMFM is the most com-
monly used instrument for detecting change in gross
motor function in children undergoing SDR. However, it
has to be kept in mind that the GMFM is constructed to
measure quantitative aspects i.e. how much children can
do, not the quality nor the performance of movements
and skills. Our impressions are that children are gaining
quality and flexibility of movements: ease, smoothness
and improved sitting which affects arm and hand func-
tion. These aspects of function are not possible to score
using the GMFM.
Prior to SDR, the children had some positive functional
effect of their spasticity. The immediate spasticity reduc-
tion after SDR facilitates flexibility and variability in lying,
sitting, crawling, and kneeling positions. However,
weight-bearing in standing, alignment and postural con-
trol in transfers and locomotion requires voluntary
strength which takes longer time to achieve postopera-
tively. As expected, there were no statistically significant
improvements during the first 6 months postoperatively.
It takes time to develop strength and to gain new func-
tional skills and use them in complex activities. Strength
was not measured pre- and postoperatively due to lack of
valid standardized measures reliable enough for assess-
ments in early pre-school years. Instead strength was esti-
mated in complex functional skills and activities.
The development in gross motor function was improved
over the five years. Thus if functional outcomes should be
detected, it is important to follow the children at least five
years postoperatively. When comparing results from dif-
ferent follow-up studies, it is important to consider differ-
ences in sample characteristics and GMFCS levels as well
as the time interval and length and frequencies of drop-
outs during the follow-ups.
Most follow-up studies present final outcomes with
GMFM-88 one to two years after SDR [9,10,12,16,20]. To
our knowledge, GMFM-66 is rarely used as the main out-
come measure. However, in the study by McLaughlin et al.
[21] both GMFM-66 and GMFM-88 were used in the
meta-analysis at 9–12 months follow-up. The mean
GMFM-66 change of scores for the pooled data was 2.7
and for GMFM-88 total score 4.5. It was concluded that
SDR and physiotherapy were effective in reducing spastic-
ity and had small positive effect on gross motor function.
In our study, the mean GMFM-66 change score at the 12
month postoperative follow-up was 3.5 and for the
GMFM-88 total score 10.9. Mittal et al. [18] presented
GMFM-88 mean change scores at 1, 3 and 5 year follow-
up of 10.1, 19.9 and 34.4 respectively. The corresponding
mean changes in our study were 10.9, 19.1 and 21.2,
respectively, which are similar during the first three years
but lower at five year follow-up. The reason for this might
Table 6: PEDI scaled scores caregiver assistance; self care and mobility.
Preop
Mean (SD)
6 m
Mean (SD)
12 m
Mean (SD)
18 m
Mean (SD)
3 yrs
Mean (SD)
5 yrs
Mean (SD)
p-value
Caregiver Assistance, Self-care
GMFCS I–II 58.7 (12.0) 61.9 (14.3) 62.5 (12.5) 67.3 (10.5) 73.2 (8.6) 88.8 (13.5) < 0.001
GMFCS III 56.1 (10.9) 61.7 (10.1) 66.1 (16.7) 65.2 (8.2) 68.5 (14.6) 72.2 (15.6) NS
GMFCS IV–V 34.9 (10.1) 42.0 (9.9) 45.0 (11.0) 47.7 (11.8) 52.3 (12.8) 53.3 (14.4) < 0.001
GMFCS I–V 46.2 (15.5) 51.9 (14.8) 54.6 (15.8) 57.0 (14.1) 61.7 (15.3) 67.2 (20.7) < 0.001
Caregiver Assistance, Mobility
GMFCS I–II 62.0 (12.8) 70.4 (11.1) 75.9 (12.2) 79.3 (13.8) 89.3 (15.3) 93.1 (10.6) < 0.001
GMFCS III 51.1 (9.1) 60.3 (8.9) 62.7 (5.8) 64.3 (9.8) 67.7 (6.2) 73.4 (11.8) 0.01
GMFCS IV–V 34.9 (10.1) 42.0 (9.9) 45.0 (11.0) 47.7 (11.8) 52.3 (12.8) 53.3 (14.4) < 0.001
GMFCS I–V 43.4 (21.4) 52.3 (18.9) 56.7 (17.5) 60.6 (18.5) 67.8 (20.1) 71.7 (19.5) < 0.001
Mean, Standard deviation (SD) for all assessments in GMFCS I–II (n = 8), GMFCS III (n = 7), GMFCS IV–V (n = 15) and the group as a whole 
(GMFCS I–V (n = 30). P-values obtained with Friedman's test: pre- 6, 12, 18 months, 3 and 5 years postoperatively.BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
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be that Mittal et al. did not include non-ambulatory chil-
dren (GMFCS IV–V).
Our results show great variability in GMFM scores
between different GMFCS levels, which has also been
reported earlier for GMFM-88 [49] and GMFM-66 [50].
Therefore, our results have been presented for the group as
a whole as well as for the three subgroups. The sample
sizes in the subgroups were small and, therefore, the
results might be influenced by type II-error. Nevertheless,
in this study, the GMFM-66 results showed statistically
significant increase in gross motor function capacity for
the separate subgroups over the 5 years.
To identify the goals of each individual child, we have
found GMFM-88 goal total score and separate GMFM-88
dimension scores useful in planning and evaluating goal-
directed interventions. All patients but one improved
their goal scores. An unexpected decline in motor func-
tion occurred in a child with preoperative GMFCS level II
(SDR at 4.9 years, Figure 4). The child was born at term.
The pregnancy, delivery and the first two years of life were
uncomplicated. A cranial tomography was performed due
to deteriorated gait at three years of age and was found to
be normal. Between this age and the SDR operation at five
years of age, no further deterioration was noted. During
the first postoperative year, motor function improved, but
later leveled off and declined. Two immobilization peri-
ods due to fractures and orthopaedic surgery probably
contributed, but a progressive disorder cannot be ruled
out.
Fifteen children in our study had preoperative gross motor
function classified as GMFCS level IV. Their mean age at
SDR operation was 4.1 years, (SD 1.7). It is known that
children with GMFCS IV–V are expected to reach 90% of
their potential GMFM-66 scores at an age of 3.5 years
(range 3.2–4.0) [50]. Many of our severely disabled chil-
dren continued to gain in motor function even after the
age of 3.5 years (Figure 3 and 6). Two children in GMFCS
level IV, who had minor improvements over the five years,
had cognitive disabilities including autism with difficul-
ties to participate in physiotherapeutic training and test
situations (SDR at 4.0 and 5.8 years). In contrast, one
child (SDR at 3.7 years) with severe mental retardation/
learning disability had a great improvement after SDR
(Figure 6).
Twice as many boys than girls were selected for SDR,
mainly reflecting gender distribution of CP spastic diple-
gia in our area (prevalence 1.3/1000 boys and 0.7/1000
girls) [51]. The best GMFM outcome was found in nine of
the 24 boys and four of the eleven girls, i.e. the proportion
is the same for boys and girls. In our study group, with a
comparatively narrow age range, age at operation did not
correlate to GMFM outcome.
PEDI was used to broaden the perspective of function and
highlight performance; assessing what the individual
child actually does in meaningful daily activities in con-
trast to capability; what they can do in specific test situa-
tions which were measured with GMFM. Traditionally,
improved walking has been a main goal for children
undergoing SDR. However, in the present study, the chil-
dren with more functional limitations (GMFCS IV–V)
never had walking as a goal. It has been shown that there
is a great variability in mobility in children with CP, even
within the same GMFCS level, due to contextual, environ-
mental and personal factors [52].
The advantages of using PEDI are to explore the parent's
view of the most common performance of the child in the
home environment and the amount of caregiver assist-
ance. In addition, it is a valuable tool in the rehabilitation
process to define functionally realistic goals and modifica-
tions needed for independence in activities in daily life. In
the present study, the largest functional improvements
appeared in the early postoperative follow-up. The
improvements continued during the five years, which is in
accordance with Mittal et al. [19]. We concluded that both
GMFM and PEDI are clinically useful for these patients
and provide complementary information on functional
outcome in a long-term follow-up.
Conclusion
SDR is a safe and effective method of reducing spasticity
permanently without major negative side effects. In com-
bination with physiotherapy, it provides lasting func-
tional benefits in a group of carefully selected and
systematically monitored young children with spastic CP.
Improvements over time were seen during the five year
follow-up period. As the goal of treatment is to improve
activities and participation, a long-term, multidisciplinary
follow-up of all the children is necessary. This cohort is
continuously and systematically monitored by the same
team to answer crucial questions about their function as
adolescents and young adults.
Abbreviations
BMI: Body Mass Index; CP: Cerebral Palsy; GMFCS: Gross
Motor Function Classification System; GMFM: Gross
Motor Function Measure; MP: Migration Percentage;
PEDI: Pediatric Evaluation of Disability Inventory;
PROM: Passive Range of Motion; SDR: Selective Dorsal
Rhizotomy.
Competing interests
The authors have no financial interest in this study, which
was performed as part of a clinical follow-up programme.BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
Page 14 of 15
(page number not for citation purposes)
Authors' contributions
EN, ALJ, JL and LW planned administrated assessments
and measurements and analyzed the results of all follow-
up data. EN, ALJ and LW wrote and revised the manuscript
with active assistance of JL, GA and LGS.
Acknowledgements
This study was supported by Medical Faculty, Lund University, The Region 
Skåne, Linnéa and Josef Carlssons Foundation and The Folke Bernadotte 
Foundation.
References
1. Flett PJ: Rehabilitation of spasticity and related problems in
childhood cerebral palsy.  J Paediatr Child Health 2003, 39(1):6-14.
2. Koman LA, Smith BP, Shilt JS: Cerebral palsy.  Lancet 2004,
363(9421):1619-1631.
3. Westbom L, Hägglund G, Lundkvist A, Nordmark E, Strömblad L-G:
New treament methods for spasticity and dystonia in chil-
dren with cerebral palsy dictate multidisciplinary teamwork.
Comprehensive approach yields good results.  Lakartidningen
2003, 100:125-130.
4. Abbot R: Complications with selective posterior rhizotomy.  J
Pediatr Neurosurg 1992, 18:43-47.
5. Hays RM, McLaughlin JF, Geiduschek JM, Bjornson KF, Graubert CS:
Evaluation of the effects of selective dorsal rhizotomy.  Ment
Retard Dev Disabil Res Rev 1997, 3(2):168-174.
6. Park TS, Owen JH: Surgical management of spastic diplegia in
cerebral palsy.  N Engl J Med 1992, 326:745-749.
7. Peacock WJ, Staudt LA: Functional outcomes following selec-
tive dorsal rhizotomy in children with cerebral palsy.  J Neu-
rosurg 1991, 74:380-385.
8. Kim HS, Steinbok P, Wickenheiser D: Predictors of poor out-
come after selective dorsal rhizotomy in treatment of spas-
tic cerebral palsy.  Child's Nerv Syst 2006, 22(1):60-66.
9. McLaughlin JF, Bjornson KF, Astley SJ, Graubert C, Hays RM, Roberts
TS, Price R, Temkin N: Selective dorsal rhizotomy: efficacy and
safety in an investigator-masked randomized clinical trial.
Dev Med Child Neurol 1998, 40(4):220-232.
10. Steinbok P, Renier AM, Beachamp R, Armstrong RW, Chochrane
DD, Kestle J: A randomized controlled trial to compare selec-
tive dorsal rhizotomy plus physiotherapy with physiotherapy
alone in children with spastic diplegic cerebral palsy.  Dev Med
Child Neurol 1997, 39:178-184.
11. Vaughan CL, Berman B, Peacock WJ: Cerebral palsy and rhizot-
omy. A 3-year follow-up evaluation with gait analysis.  J Neu-
rosurg 1991, 74:178-184.
12. Wright FV, Sheil EM, Drake JM, Wedge JH, Naumann S: Evaluation
of selective dorsal rhizotomy for the reduction of spasticity
in cerebral palsy: a randomized controlled tria.  Dev Med Child
Neurol 1998, 40(4):239-247.
13. International Classification of Functioning, Disability and
Health (ICF).  Geneva, Switzerland: World Health Organization;
2001. 
14. Nordmark E, Andersson G: Wartenberg pendulum test: objec-
tive quantification of muscle tone in children with spastic
diplegia undergoing selective dorsal rhizotomy.  Dev Med Child
Neurol 2002, 44(1):26-33.
15. Steinbok P: Outcomes after selective dorsal rhizotomy for
spastic cerebral palsy.  Child's Nervous System 2001, 17:1-2.
16. Cole GF, Farmer SE, Roberts A, Stewart C, Patrick JH: Selective
dorsal rhizotomy for children with cerebral palsy: the
Oswestry experience.  Arch Dis Child 2007, 92(9):781-785.
17. Engsberg JR, Ross SA, Collins DR, Park TS: Effect of selective dor-
sal rhizotomy in the treatment of children with cerebral
palsy.  J Neurosurg 2006, 105(1 Suppl):8-15.
1 8 . M i t t a l  S ,  F a r m e r  J - P ,  A l - A t a s s i  B ,  G i b i s  J ,  K e n n e d y  E ,  G a l l i  C ,
Courchesnes G, Poulin C, Cantin MA, Benaroch TE: Long-term
functional outcome after selective posterior rhizotomy.  J
Neurosurg 2002, 97(2):315-325.
19. Mittal S, Farmer J-P, Al-Atassi B, Montpetit K, Gervais N, Poulin C,
Benaroch TEMAC: Functional performance following selective
posterior rhizotomy: long-term results determine using a
validated evaluative measure.  J Neurosurg 2002, 97(3):510-518.
20. Nordmark E, Jarnlo G-B, Hagglund G: Comparison of the Gross
Motor Function Measure and Paediatric Evaluation of Disa-
bility Inventory in assessing motor function in children
undergoing selective dorsal rhizotomy.  Dev Med Child Neurol
2000, 42(4):245-252.
21. McLaughlin J, Bjornson K, Temkin N, Steinbok P, Wright V, Reiner A,
Roberts T, Drake J, O'Donnell M, Rosenbaum P, et al.: Selective
dorsal rhizotomy: meta-analysis of three randomized con-
trolled trials.  Dev Med Child Neurol 2002, 44(1):17-25.
22. Langerak NG, Lamberts RP, Fieggen AG, Peter JC, Merwe L van der,
Peacock WJ, Vaughan CL: A prospective gait analysis study in
patients with diplegic cerebral palsy 20 years after selective
dorsal rhizotomy.  J Neurosurg Pediatrics 2008, 1(3):180-186.
23. Subramanian N, Vaughan CL, Peter JC, Arens CJ: Gait before and
10 years after rhizotomy in children with cerebral palsy spas-
ticity.  J Neurosurg 1998, 88:1014-1019.
24. O'Brien DF, Park TS, Puglisi JA, Collina DR, Leuthardt EC, Leonard
JR: Orthopedic surgery after selective dorsal rhizotomi for
spastic children in relation to ambulatory status and age.  J
Neurosurg 2005, 103(1 Suppl):5-9.
25. Hicdonmez T, Steinbok P, Beauchamp R, Sawatzky B: Hip joint sub-
luxation after selective dorsal rhizotomi for spastic cerebral
palsy.  J Neurosurg (Pediatrics) 2005, 103:10-16.
26. Farmer J-P, Sabbagh AJ: Selective dorsal rhizotomies in the
treatment of spasticity related to cerebral palsy.  Child's Nerv
Syst 2007, 23(9):991-1002.
27. Johnson MB, Goldstein L, Thomas SS, Piatt J, Aiona M, Sussman M:
Spinal deformity after selective dorsal rhizotomy in ambula-
tory patients with cerebral palsy.  J Pediatr Orthop 2004,
24(5):529-536.
28. Steinbok P, Hicdonmez T, Sawatzky B, Beauchamp R, Wickenheiser
D: Spinal deformaties after selective dorsal rhizotomy for
spastic cerebral palsy.  J Neurosurg 2005, 102(4 Supple-
ment):363-373.
29. Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV: Cerebral
palsy epidemiology: where are we now and where are we
going?  Dev Med Child Neurol 1992, 34(6):547-551.
30. Hagberg B, Hagberg G, Olow I: The changing panorama of cere-
bral palsy in Sweden 1954–1970.  Acta Paediatr Scand 1975,
64:178-192.
31. Palisano RJ, Rosenbaum P, Walter SD, Russell D, Wood E, Galuppi B:
Development and reliability of a system to classify gross
motor function in children with cerebral palsy.  Dev Med Child
Neurol 1997, 39:214-223.
32. Wikland KA, Luo ZC, Niklasson A, Karlberg J: Swedish population-
based longitudinal reference values from birth to 18 years of
age for height, weight and head circumference.  Acta Paediatr
2002, 91(7):739-754.
33. Peacock WJ, Arens LJ: Selective posterior rhizotomy for the
relief of spasticity in cerebral palsy.  S Afr Med J 1982,
62:119-124.
34. Peacock WJ, Staudt LS, Nuwer MR: A neurosurgical approach to
spasticty.  In Neurosurgery Update II Edited by: Wilkins R, Ren-
gacheery S. New York, USA: McGraw Hill; 1990:403-407. 
35. Hesselgard K, Strömblad L-G, Reinstrup P: Morphine with or with-
out a local anaesthetic for postoperative intrathecal pain
treatment after selective dorsal rhizotomy in children.  Pae-
diatr Anaesth 2001, 11:75-79.
36. Karlberg J, Kwan CW, Albertsson-Wikland K: Reference values for
change in body mass index from birth to 18 years of age.  Acta
Paediatr 2003, 92(6):648-652.
37. Manschot S, van Passel L, Buskens E, Algra A, van Gijn J: Mayo and
NINDS scales for assessment of tendon reflexes: between
observer agreement and implications for communication.  J
Neurol Neurosurg Psychiatry 1998, 64:253-255.
38. AAoOS: Joint Motion. Method of Measuring and recording.
American Academy of Orthopaedic Surgeons.  14th edition.
Edinburgh: Churchill Livingstone; 1965. 
39. Russell DJ, Rosenbaum PL, Avery LM, Lane M: Gross Motor Func-
tion Measure (GMFM-66 and GMFM-88). User's manual.
London: Mac Keith Press; 2002. 
40. Haley SM, Coster WJ, Ludlow L, Haltiwanger JT, Andrellos PJH: Pea-
diatric Evaluation Disability Inventory (PEDI). Version 1,0.
Boston, MA, USA: New England Medical Centre Hospitals, Inc; 1992. Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pediatrics 2008, 8:54 http://www.biomedcentral.com/1471-2431/8/54
Page 15 of 15
(page number not for citation purposes)
41. Nordmark E, Orban K: Pediatric Evaluation of Disability Inven-
tory, PEDI. Swedish edition.  In Center for Rehabilitation Effective-
ness, Sargent College of Health and Rehabilitation Sciences, 635
Commonwealth Avenue, Boston, MA 02215-1605 USA Swedish version:
Psykologiförlaget AB; 1999. 
42. Lundkvist A, Hagglund G: Orthopaedic surgery after selective
dorsal rhizotomy.  J Pediatr Orthop B 2006, 15(4):244-246.
43. Steinbok P: Selective dorsal rhizotomy for spastic cerebral
palsy: a review.  Child's Nerv Syst 2007, 23(9):981-990.
44. Graham HK: The trials of trials.  Dev Med Child Neurol 2007,
49(3):163.
45. Horn SD, Gassaway J: Practice-based evidence study design for
comparative effectiveness research.  Med Care 2007, 45(10
Supl 2):S50-57.
46. Carroll KL, Moore KR, Stevens PM: Orthopedic procedures after
rhizotomy.  J Pediatr Orthop 1998, 18(1):69-74.
47. Golan JD, Hall JA, O'Gorman G, Poulin C, Benaroch TE, Cantin MA,
Farmer JP: Spinal deformities following selective dorsal rhizo-
tomy.  J Neurosurg 2007, 106(6 Suppl):441-449.
48. Stevenson RD, Conaway MW, Chumlea C, Rosenbaum P, Fung EB,
Henderson RC, Worley G, Liptak G, O'Donnell M, Samson-Fang L, et
al.: Growth and health in children with moderate-to-severe
cerebral palsy.  Pediatrics 2006, 118:1010-1018.
49. Beckung E, Carlsson G, Carlsdotter S, Uvebrant P: The natural his-
tory of gross motor development in children with cerebral
palsy aged 1 to 15 years.  Dev Med Child Neurol 2007,
49(10):751-756.
50. Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P,
Wood E, Bartlett DJ, Galuppi BE: Prognosis for gross motor func-
tion in cerebral palsy: creation of motor development
curves.  Jama 2002, 288(11):1357-1363.
51. Westbom L, Hagglund G, Nordmark E: Cerebral palsy in a total
population of 4–11 year olds in southern Sweden. Prevalence
and distribution according to different CP classification sys-
tems.  BMC Pediatr 2007, 7:41.
52. Tieman B, Palisano R, Gracely EJ, Rosenbaum PL: Variability in
mobility of children with cerebral palsy.  Pediatr Phys Ther 2007,
19:180-187.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2431/8/54/prepub